Lymph Node Harvest in Esophageal Cancer After Neoadjuvant Chemoradiotherapy

[1] Siegel R(2011)Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin. 61 212-236

[2] Ward E(2011)Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis Lancet Oncol. 12 681-692

[3] Brawley O(2008)Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer Cancer. 112 1239-1246

[4] Jemal A(2011)The total number of resected lymph node is not a prognostic factor for recurrence in esophageal squamous cell carcinoma patients undergone transthoracic esophagectomy J Surg Oncol. 103 416-420

[5] Sjoquist KM(2008)The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg. 248 549-556

[6] Burmeister BH(2010)Optimum lymphadenectomy for esophageal cancer Ann Surg. 251 46-50

[7] Smithers BM(2007)Clinical impact of lymphadenectomy extent in resectable esophageal cancer J Gastrointest Surg 11 1384-1393

[8] Zalcberg JR(2010)Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer Ann Surg Oncol. 17 1159-1167

[9] Simes RJ(2012)Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy Ann Surg Oncol. 19 1678-1684

[10] Barbour A(2011)Improved survival in patients with lymph node-positive gastric cancer who received preoperative radiation: an analysis of the surveillance, epidemiology, and end results database Cancer. 117 3908-3916

[1] Siegel R(2011)Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin. 61 212-236

[2] Ward E(2011)Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis Lancet Oncol. 12 681-692

[3] Brawley O(2008)Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer Cancer. 112 1239-1246

[4] Jemal A(2011)The total number of resected lymph node is not a prognostic factor for recurrence in esophageal squamous cell carcinoma patients undergone transthoracic esophagectomy J Surg Oncol. 103 416-420

[5] Sjoquist KM(2008)The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg. 248 549-556

[6] Burmeister BH(2010)Optimum lymphadenectomy for esophageal cancer Ann Surg. 251 46-50

[7] Smithers BM(2007)Clinical impact of lymphadenectomy extent in resectable esophageal cancer J Gastrointest Surg 11 1384-1393

[8] Zalcberg JR(2010)Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer Ann Surg Oncol. 17 1159-1167

[9] Simes RJ(2012)Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy Ann Surg Oncol. 19 1678-1684

[10] Barbour A(2011)Improved survival in patients with lymph node-positive gastric cancer who received preoperative radiation: an analysis of the surveillance, epidemiology, and end results database Cancer. 117 3908-3916